Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 531.70
+2.70 (0.51%)
At close: Dec 4, 2025
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 1.35 billion as of December 5, 2025. Its market cap has increased by 117.33% in one year.
Market Cap
1.35B
Enterprise Value
1.22B
Revenue
35.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
531.70
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 1.35B, an increase of 2,628.85%. That is a compound annual growth rate of 10.34%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 105.66B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 1.33B |
| BrainsWay | 1.08B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 997.78M |
| Ilex Medical | 717.72M |
| Novolog (Pharm-Up 1966) | 644.72M |